Study: Artificial Intelligence for Early Detection of Pediatric Eye Diseases Using Mobile Photos
In a study published online in JAMA Network Open on August 6, an AI model demonstrates high performance in correctly recognizing myopia, strabismus, and ptosis using smartphone images.
In a cross-sectional study, Qin Shu, M.D., of Shanghai Jiao Tong University School of Medicine, and associates created an AI model to recognize myopia, strabismus, and ptosis using cellphone photos. The model was constructed from 1,419 pictures, representing 476 patients. Of the pictures, 473 binocular and 946 monocular images were utilized to diagnose strabismus and myopia, respectively.
The model’s sensitivity for identifying ptosis, strabismus, and myopia was shown to be good (0.84, 0.73, and 0.85, respectively). The model demonstrated similar effectiveness in diagnosing eye diseases in children, both male and female, during sex subgroup analysis. There were variations in the ability to diagnose eye conditions among various age groups.
“The detection model using AI showed strong performance in accurately identifying myopia, strabismus, and ptosis using only smartphone images,” the authors write. “These results suggest that it can assist families in screening children for myopia, strabismus, and ptosis, facilitating early identification and reducing the risk of visual function loss and severe problems due to delayed screening.”
For more information: Artificial Intelligence for Early Detection of Pediatric Eye Diseases Using Mobile Photos, JAMA Network Open , DOI: 10.1001/jamanetworkopen.2024.25124
more recommended stories
HEALEY Platform Accelerates ALS Therapy ResearchA New Era of ALS Clinical.
Low-Oxygen Therapy in a HypoxyStat Pill? Scientists Say It’s PossibleA New Approach to Oxygen Regulation-HypoxyStat.
Early Alzheimer’s Diagnosis with Advanced Tau TestA New Biomarker Test Promises Early.
AI and 3D Printing Unlock New Neuron Growth Insights3D-Printing Brain Model Unlocks Neuron Growth.
AI Uncovers Hidden Pregnancy Risks for StillbirthA groundbreaking AI-driven study has identified.
Harvard Study Unveils New TB Drug RegimensA Harvard Medical School-led clinical trial.
Affordable AI Tool Predicts Cancer Immunotherapy OutcomesResearchers from Memorial Sloan Kettering Cancer.
Inogen’s SIMEOX 200 Gets FDA Clearance for Airway CareInogen, Inc., a medical technology company.
AI System Tracks Emerging infectious DiseaseResearchers have developed a novel method.
Psilocybin Helps Reduce Anxiety, Depression During CancerGroundbreaking research from NYU Langone Health.
Leave a Comment